Division of Tuberculosis Elimination (EIS 2022)

The mission of the Division of Tuberculosis Elimination (DTBE) is to provide leadership in preventing, controlling, and eventually eliminating tuberculosis (TB) from the United States, in collaboration with partners at the community, state, and international levels.

Key activities:

• Monitoring progress toward TB elimination through national TB surveillance
• Strengthening the capacity of health departments and other partners to prevent, control, and eventually eliminate TB through improved communications, information dissemination, education, and training
• Using contact investigations to prevent TB among persons at highest risk, including those with HIV infection
• Building outbreak detection and response capability
• Investigating improved treatment regimens
• Providing technical assistance, including programmatic support, research, and the identification, treatment, and management of multidrug-resistant (MDR) TB, extensively drug-resistant (XDR) TB, and TB among the most vulnerable populations (e.g., children, correctional populations, people experiencing homelessness)

Philip LoBue, MD

Director

Kathryn Koski, MSEd, MPH

Deputy Director

Carla Winston, PhD, MA

Associate Director for Science

Adam Langer DVM, MPH

(EIS 2006)
Chief, Surveillance, Epidemiology, and Outbreak Investigations Branch

Sandy Althomsons, MA, MHS

Justin Davis, MPH

Molly Deutsch-Feldman, PhD, MPH

(EIS 2020)

Maryam Haddad, PhD, MSN, MPH

(Primary Supervisor)
(EIS 2001)

Andrew Hill, PhD

J. Steve Kammerer, MBA

Clint McDaniel, MPH

Roque Miramontes, PA-C, MPH

(EIS 2006)
Chief, Data Management, Statistics, and Evaluation Branch

Kala Marks Raz, MPH

Noah Schwartz, MD

(Secondary Supervisor)
(EIS 2019)

Julie Self, PhD, MPH

(Secondary Supervisor)
(EIS 2015)

Rebekah (Becky) Stewart, MSN, MPH, APRN

(EIS 2015)

Sarah Talarico, PhD

(Secondary Supervisor)

Billy Walker, DVM, PhD

(EIS 2016)

Jonathan Wortham, MD

(EIS 2011)